Satoshi Tanaka

6PUBLICATIONS
17CO-AUTHORS
Tumour immunologyPredictive and prognostic markersNutritional epidemiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 08, 2025
Lymphocyte-to-Monocyte Ratio as a Practical Biomarker for Immunotherapy Response in Hepatocellular Carcinoma.

Satoshi Tanaka

|Feb 25, 2022
Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy.

Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori

|Oct 26, 2021
Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus.

Aya Ishizaka, Michiko Koga, Taketoshi Mizutani

|Dec 08, 2020
ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma.

Yuta Myojin, Takahiro Kodama, Kazuki Maesaka

|Aug 13, 2020
Hepatocellular carcinoma in an adult patient with congenital absence of the portal vein type II: A case report.

Hiroki Bessho, Satoshi Tanaka, Akio Ishihara

|Nov 27, 2015
S100A8 Production in CXCR2-Expressing CD11b+Gr-1high Cells Aggravates Hepatitis in Mice Fed a High-Fat and High-Cholesterol Diet.

Kaori Mukai, Takuya Miyagi, Kumiko Nishio

Pageof 1

Frequent Collaborators

3 joint publications

Ryotaro Sakamori

1 joint publications

Kaori Mukai

1 joint publications

Yoshinobu Saito

1 joint publications

Naoki Hiramatsu